Paul Tudor Jones United Therapeutics Corp Transaction History

Tudor Investment Corp Et Al

$25.1 Billion
Q4 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in United Therapeutics Corp stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 22,387 shares of UTHR stock, worth $6.87 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

22,387

Previous 9,346 139.54%

Holding current value

$6.87 Million

Previous $3.35 Million 135.86%

% of portfolio

0.03%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$348.66 - $410.0 $4.55 Million - $5.35 Million	13,041 Added 139.54%	22,387 $7.9 Million
Q3 2024 Nov 14, 2024	BUY	$311.04 - $363.55 $2.91 Million - $3.4 Million	9,346 New	9,346 $3.35 Million
Q4 2023 Feb 14, 2024	BUY	$214.88 - $256.94 $4.32 Million - $5.16 Million	20,084 New	20,084 $4.42 Million
Q2 2022 Aug 15, 2022	BUY	$174.81 - $241.14 $571,978 - $789,010	3,272 New	3,272 $771,000
Q3 2020 Nov 16, 2020	SELL	$99.9 - $121.13 $566,632 - $687,049	-5,672 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$92.74 - $125.82 $526,021 - $713,651	5,672 New	5,672 $686,000
Q1 2020 May 15, 2020	SELL	$79.39 - $115.35 $2.87 Million - $4.17 Million	-36,171 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$78.31 - $95.34 $1.7 Million - $2.06 Million	21,657 Added 149.21%	36,171 $3.19 Million
Q3 2019 Nov 14, 2019	SELL	$74.85 - $85.99 $2.95 Million - $3.39 Million	-39,426 Reduced 73.09%	14,514 $1.16 Million
Q2 2019 Aug 14, 2019	BUY	$76.06 - $120.81 $4.1 Million - $6.52 Million	53,940 New	53,940 $4.21 Million
Q1 2019 May 15, 2019	SELL	$107.15 - $126.84 $826,983 - $978,951	-7,718 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$101.4 - $128.73 $771,045 - $978,862	-7,604 Reduced 49.63%	7,718 $840,000
Q3 2018 Nov 14, 2018	BUY	$113.81 - $129.46 $525,346 - $597,587	4,616 Added 43.12%	15,322 $1.96 Million
Q2 2018 Aug 14, 2018	BUY	$101.14 - $118.31 $1.08 Million - $1.27 Million	10,706 New	10,706 $1.21 Million
Q1 2018 May 15, 2018	SELL	$107.21 - $151.94 $437,952 - $620,674	-4,085 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$118.58 - $151.28 $437,797 - $558,525	-3,692 Reduced 47.47%	4,085 $604,000
Q3 2017 Nov 14, 2017	BUY	$114.6 - $136.81 $891,244 - $1.06 Million	7,777	7,777 $911,000

Others Institutions Holding UTHR

# of Institutions

725

Shares Held

61M

Call Options Held

123K

Put Options Held

104K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $14B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account